Fampyra (fam-PEER-ah, fampridine), a new oral therapy for multiple sclerosis

Patients will be able to try Fampyra (fam-PEER-ah, fampridine), a new oral therapy for multiple sclerosis.

Multiple sclerosis affects the brain, spinal cord, and nerves. There are about 2.5 million people worldwide with multiple sclerosis.

Fampyra's claim to fame is that it improves walking speed in patients with multiple sclerosis. This is different than other multiple sclerosis drugs...which work to reduce disease relapses.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote